
Cancer care must be made a priority during the 2022 Quebec provincial general election
On October 3, 2022, Quebecers will go to the polls to elect their next government. Given that the COVID-19 pandemic has been raging for more than two years, it has never been more important to prioritize the needs of people with cancer and their loved ones.
Cancer remains the leading cause of death in the country and an estimated two in five Quebecers will be diagnosed with cancer in their lifetime. Cancer hasn’t taken a break during the pandemic, and oncology care and services have suffered the consequences.
Take concrete action during the 2022 provincial general election@(headingTag)>
CCS estimates indicate that in 2021, 6,400 Quebecers were diagnosed with this type of cancer and 2,600 died from it.
Screening for early detection of this type of cancer is the key to increasing the survival rate of those affected. Indeed, the five-year survival rate is 90% when the disease is detected at an early stage, compared to only 13% when it is detected at an advanced stage.
Send a letter to your party leaders
CCS’s three main recommendations for the 2022 Quebec general election:@(headingTag)>
Party questionnaire responses
We are pleased to share that several parties responded to our questionnaire. You can read the full questionnaire responses below. The responses to the questionnaire are presented exactly as we received them, therefore none of the responses have been translated into English.
Please note that the Parti Conservateur du Québec has decided not to participate in this CCS initiative.
Help amplify the voices of people affected by cancer
Changing public policy is one of the most effective tools for preventing cancer and helping those affected by it.
With just $5 from people like you, we can continue to connect government decision-makers with thousands of patients and caregivers to make cancer care better, everywhere in Canada.
If everyone reading this gave just $5, we could achieve our goal this month to fund transformative advocacy, the most promising research, and reliable cancer information and support. Please give today. Thank you.